Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a single center, double-blind, randomized, placebo-controlled, ascending, single dose study of PRT064445 or its matching placebo, in healthy subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PRT0064445 Dose 1 | Experimental | Dose 1 versus Placebo |
|
| PRT064445 Dose 2 | Experimental | Dose 2 versus Placebo |
|
| PRT064445 Dose 3 | Experimental | Dose 3 versus Placebo |
|
| PRT064445 Dose 4 | Experimental | Dose 4 versus Placebo |
|
| PRT064445 Dose 5 | Experimental | Dose 5 versus Placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PRT064445 | Biological | Intravenous |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pharmacodynamics assessments | Up to 28 days |
| Measure | Description | Time Frame |
|---|---|---|
| Pharmacokinetics: Plasma levels of PRT064445 | Up to 7 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Phoenix | Arizona | 85283 | United States |
Not provided
| ID | Term |
|---|---|
| C580915 | PRT064445 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Intravenous to mimic PRT064445 |
|
|